DARPA’s SHIELD Program: Revolutionizing Combat Medicine Through Infection Immunotherapy

Bloodstream infections (BSIs) remain one of the deadliest complications in trauma care—particularly in combat environments where gunshot wounds, burns, and blast injuries create the ideal conditions for bacterial and fungal pathogens to thrive. Traditional treatments rely on pathogen identification and delayed antibiotic administration, a reactive model that often proves fatal in forward operating settings. To…